1. | | Recruiting | Carboplatin Plus Paclitaxel With or Without Continued Low-Dose Paclitaxel in Treating Patients With Early-Stage Ovarian Cancer Conditions: stage I ovarian epithelial cancer; stage II ovarian epithelial cancer; ovarian undifferentiated
adenocarcinoma; ovarian mixed epithelial carcinoma; ... |
2. | | Recruiting | Flavopiridol and Paclitaxel in Treating Patients With Locally Advanced or Metastatic Esophageal Cancer That Has Not Responded to Previous Paclitaxel Conditions: stage III esophageal cancer; stage IV esophageal cancer; recurrent esophageal cancer; squamous cell carcinoma of the esophagus; ... |
3. | | Recruiting | A Phase II Trial of Trastuzumab and Paclitaxel in Patients with HER2 Overexpressing Breast and Ovarian Tumors Who Have Relapsed or Progressive Disease Following Conventional Cytotoxic Chemotherapy ... Conditions: Breast Neoplasm; Neoplasm Metastasis; Ovarian Neoplasm |
4. | | Recruiting | CT-2103 Plus Carboplatin Compared With Paclitaxel Plus Carboplatin in Treating Patients With Advanced or Recurrent Non-Small Cell Lung Cancer Conditions: recurrent non-small cell lung cancer; stage IIIB non-small cell lung cancer; stage IV non-small cell lung cancer |
5. | | Recruiting | Evaluation of BNP7787 for the Prevention of Neurotoxicity in Metastatic Breast Cancer Patients Receiving Weekly Paclitaxel Conditions: Breast
Neoplasms; Breast Diseases; Metastases, Neoplasm |
6. | | Recruiting | Combination Chemotherapy Followed by Radiation Therapy With or Without Paclitaxel in Treating Patients With Unresectable Stage III Non-Small Cell Lung Cancer Conditions: recurrent non-small cell lung cancer; stage IIIA non-small cell lung cancer; stage IIIB non-small cell lung cancer |
7. | | Recruiting | Trastuzumab With or Without Paclitaxel in Treating Women With Metastatic Breast Cancer That Overexpresses HER2 Conditions: stage IV breast cancer; stage IIIA breast cancer; recurrent breast cancer; stage IIIB breast cancer |
8. | | No longer recruiting | Paclitaxel in Advanced Refractory Kaposi's Sarcoma (AIDS-KS): A Phase II Trial of Paclitaxel from Baker Norton Pharmaceuticals Conditions: Sarcoma,
Kaposi; HIV Infections |
9. | | Completed | Micellar Paclitaxel to Treat Severe Psoriasis Condition: Psoriasis |
10. | | Recruiting | Carboplatin and Paclitaxel With or Without Gemcitabine in Treating Patients With Ovarian Epithelial or Fallopian Tube Cancer Conditions: stage I ovarian epithelial cancer; stage II ovarian epithelial cancer; stage III ovarian epithelial cancer; stage IV ovarian epithelial cancer; ... |
11. | | Recruiting | Paclitaxel and Carboplatin With or Without Epirubicin in Treating Patients With Stage IIB, Stage III, or Stage IV Invasive Ovarian Epithelial, Fallopian Tube, or Peritoneal Cancer Conditions: stage II ovarian epithelial cancer; stage III ovarian epithelial cancer; stage IV ovarian epithelial cancer; fallopian tube cancer; ... |
12. | | Recruiting | Monoclonal Antibody Therapy, Paclitaxel, and Cyclosporine in Treating Patients With Recurrent or Refractory Non-Hodgkin's Lymphoma Conditions: recurrent grade I follicular small cleaved cell lymphoma; recurrent grade II follicular mixed cell lymphoma; ... |
13. | | Not yet recruiting | Suramin and Paclitaxel in Treating Women With Stage IIIB or Stage IV Breast Cancer Conditions: recurrent breast cancer; stage IIIB breast cancer; stage IV breast cancer |
14. | | Recruiting | Doxorubicin and Cisplatin With or Without Paclitaxel in Treating Patients With Endometrial Cancer Conditions: recurrent endometrial cancer; stage III endometrial cancer; stage IV endometrial cancer |
15. | | Recruiting | Paclitaxel Plus Radiation Therapy in Treating Women With Stage II or Stage III Breast Cancer Conditions: stage II breast cancer; stage IIIA breast cancer; stage IIIB breast cancer |
16. | | Recruiting | Radiation Therapy, Paclitaxel, and Cisplatin in Treating Patients With Cancer of the Cervix Conditions: stage III cervical cancer; stage IVA cervical cancer; cervical squamous cell carcinoma; cervical
adenocarcinoma; ... |
17. | | Recruiting | Radiation Therapy Plus Paclitaxel and Cisplatin in Treating Patients With Cervical Cancer Conditions: stage III cervical cancer; stage IB cervical cancer; stage IIB cervical cancer; stage IIA cervical cancer; stage IVA cervical cancer; ... |
18. | | Recruiting | Paclitaxel and Bryostatin-1 in Treating Patients With Locally Advanced Unresectable or Metastatic Pancreatic Cancer Conditions: stage II pancreatic cancer; stage III pancreatic cancer; recurrent pancreatic cancer; adenocarcinoma of the pancreas; stage IVA pancreatic cancer; ... |
19. | | Recruiting | Paclitaxel Plus Radiation Therapy in Treating Children With Newly Diagnosed Brain Stem Glioma Condition: untreated childhood brain stem glioma |
20. | | Recruiting | Paclitaxel With or Without Trastuzumab in Treating Patients With Inoperable, Recurrent, or Metastatic Breast Cancer Conditions: stage IV breast cancer; recurrent breast cancer; stage IIIB breast cancer |
21. | | Recruiting | Paclitaxel or Docetaxel in Treating Women With Advanced Breast Cancer Conditions: stage IV breast cancer; stage IIIA breast cancer; recurrent breast cancer; stage IIIB breast cancer |
22. | | Recruiting | Monoclonal Antibody Therapy, Cyclosporine, and Paclitaxel in Treating Patients With Recurrent or Refractory Metastatic Breast Cancer Conditions: stage IV breast cancer; recurrent breast cancer |
23. | | Recruiting | Erlotinib, Trastuzumab, and Paclitaxel in Treating Patients With Advanced Solid Tumors Condition: unspecified adult solid tumor, protocol specific |
24. | | Recruiting | Ifosfamide With or Without Paclitaxel in Treating Patients With Advanced, Refractory, or Recurrent Cancer of the Uterus Conditions: stage III uterine sarcoma; stage IV uterine sarcoma; recurrent uterine sarcoma; uterine carcinosarcoma |
25. | | Recruiting | ABX-EGF in Combination with Paclitaxel and Carboplatin for the Treatment of Advanced Non-Small-Cell Lung Cancer (NSCLC) Conditions: Carcinoma, Non-Small-Cell Lung Neoplasm; Neoplasm Metastasis; Lung Cancer |
26. | | Recruiting | Carboplatin, Paclitaxel, and Radiation Therapy With or Without Thalidomide in Treating Patients With Stage III Non-small Cell Lung Cancer Conditions: squamous cell lung cancer; large cell lung cancer; stage IIIA non-small cell lung cancer; stage IIIB non-small cell lung cancer; ... |
27. | | Recruiting | DHA-Paclitaxel in Treating Patients With Metastatic Prostate Cancer Conditions: adenocarcinoma of the prostate; stage IV prostate cancer; recurrent prostate cancer |
28. | | Recruiting | DHA-Paclitaxel in Treating Patients With Metastatic Pancreatic Cancer Conditions: recurrent pancreatic cancer; stage IVA pancreatic cancer; stage IVB pancreatic cancer |
29. | | Recruiting | Paclitaxel, Ifosfamide, and Cisplatin in Treating Patients With Metastatic Testicular Cancer Conditions: stage III testicular cancer; recurrent testicular cancer; testicular embryonal carcinoma; testicular
choriocarcinoma; testicular teratoma; ... |
30. | | Recruiting | Oxaliplatin and Paclitaxel in Treating Patients With Metastatic or Unresectable Cancer Condition: unspecified adult solid tumor, protocol specific |
31. | | Recruiting | Bevacizumab, Paclitaxel, and Carboplatin Before Surgery in Treating Patients With Stage IB, Stage II, or Stage IIIA Non-Small Cell Lung Cancer Conditions: stage I non-small cell lung cancer; stage II non-small cell lung cancer; stage IIIA non-small cell lung cancer |
32. | | Recruiting | SU5416 and Paclitaxel in Treating Patients With Recurrent, Locally Advanced or Metastatic Cancer of the Head and Neck Conditions: medullary thyroid cancer; anaplastic thyroid cancer; recurrent thyroid cancer; recurrent salivary gland cancer; ... |
33. | | Recruiting | Platinum-based Chemotherapy With or Without Paclitaxel in Treating Patients With Relapsed Ovarian Cancer Conditions: recurrent ovarian epithelial cancer; peritoneal cavity cancer |
34. | | Recruiting | Suramin, Paclitaxel, and Carboplatin in Treating Patients With Stage IIIB or Stage IV Non-small Cell Lung Cancer Conditions: recurrent non-small cell lung cancer; stage IIIB non-small cell lung cancer; stage IV non-small cell lung cancer |
35. | | Recruiting | Cisplatin, Paclitaxel, and Gemcitabine in Treating Patients With Progressive Unresectable Regional or Metastatic Bladder Cancer Conditions: stage III bladder cancer; stage IV bladder cancer; transitional cell carcinoma of the bladder |
36. | | Recruiting | Dimesna in Treating Patients With Solid Tumors Who Are Undergoing Treatment With Cisplatin and Paclitaxel Conditions: stage III non-small cell lung cancer; recurrent non-small cell lung cancer; stage III ovarian epithelial cancer; stage IV ovarian epithelial cancer; ... |
37. | | Recruiting | Paclitaxel in Treating Older Patients With Solid Tumors Condition: unspecified adult solid tumor, protocol specific |
38. | | Recruiting | Phase I Study of PEG-Paclitaxel In Patients with Advanced Solid Tumors & Lymphomas Conditions: Neoplasm; Lymphomas; Neoplasm Metastasis |
39. | | Recruiting | Gemcitabine and Paclitaxel in Treating Patients With Advanced or Recurrent Cancer of the Urinary Tract Conditions: recurrent bladder cancer; stage IV bladder cancer; transitional cell carcinoma of the bladder; squamous cell carcinoma of the bladder; ... |
40. | | Recruiting | Capecitabine and Paclitaxel in Treating Patients With Metastatic Breast Cancer Conditions: stage IV breast cancer; recurrent breast cancer |
41. | | Recruiting | Docetaxel or Paclitaxel in Treating Women With Unresectable Locally Advanced or Metastatic Breast Cancer Conditions: stage IV breast cancer; stage IIIA breast cancer; recurrent breast cancer; stage IIIB breast cancer |
42. | | Recruiting | Cisplatin Plus Gemcitabine With or Without Paclitaxel in Treating Patients With Stage IV Urinary Tract Cancer Conditions: stage IV bladder cancer; transitional cell carcinoma of the bladder; urethral cancer associated with invasive bladder cancer; ... |
43. | | Recruiting | Paclitaxel in Treating Patients With Ovarian Stromal Cancer Condition: ovarian stromal cancer |
44. | | Recruiting | Interleukin-12, Paclitaxel, and Trastuzumab in Treating Patients With Solid Tumors Conditions: recurrent breast cancer; recurrent gastric cancer; recurrent non-small cell lung cancer; recurrent ovarian epithelial cancer; ... |
45. | | Recruiting | Paclitaxel, Cisplatin, and Topotecan With or Without Filgrastim in Treating Patients With Newly Diagnosed Stage III or Stage IV Epithelial Ovarian Cancer Conditions: stage III ovarian epithelial cancer; stage IV ovarian epithelial cancer; ovarian undifferentiated
adenocarcinoma; ovarian mixed epithelial carcinoma; ... |
46. | | Recruiting | Bryostatin 1 Plus Paclitaxel in Treating Patients With Locally Advanced or Metastatic Esophageal Cancer or Stomach Cancer Conditions: stage III gastric cancer; stage IV gastric cancer; recurrent gastric cancer; stage III esophageal cancer; stage IV esophageal cancer; ... |
47. | | Recruiting | Paclitaxel and Carboplatin in Treating Patients With Metastatic Prostate Cancer That Has Not Responded to Hormone Therapy Conditions: adenocarcinoma of the prostate; recurrent prostate cancer; stage IV prostate cancer |
48. | | Recruiting | Carboplatin Combined with Paclitaxel in Treating Patients With Advanced Thymoma Conditions: invasive malignant
thymoma; recurrent malignant thymoma |
49. | | Recruiting | Doxorubicin, Cyclophosphamide, and Paclitaxel With or Without Filgrastim in Treating Women With Inflammatory or Locally Advanced Breast Cancer Conditions: stage II breast cancer; stage IIIA breast cancer; stage IIIB breast cancer; inflammatory breast cancer |
50. | | Recruiting | Paclitaxel in Treating Patients With Locally Advanced, Metastatic, or Recurrent Cancer of the Vulva Conditions: stage III vulvar cancer; stage IV vulvar cancer; recurrent vulvar cancer; squamous cell carcinoma of the vulva |